EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

The Long-Term Cardiovascular Risks of Proton Pump Inhibitors (PPIs): A Meta-Analysis of Observational and Randomized Trials

Muhammad Raza Abbas, Hamna Hussain, Mudassir Abbas, Urooba Qazi, Mamoona Rafique, Iqra Batool, Adeen Mir

Indus Journal of Bioscience Research · 31.03.2025 · 3 (3) · 77-83

DOI: 10.70749/ijbr.v3i3.913 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 25.03.2025. Verfasst von Muhammad Raza Abbas und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs) are widely used for the treatment of acid-related disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers. However, emerging evidence suggests that long-term PPI use may be associated with an increased risk of adverse cardiovascular events, including ischemic stroke, myocardial infarction, cardiac arrest, and cardiovascular mortality. Despite numerous observational studies and randomized controlled trials (RCTs) investigating this association, the evidence remains inconclusive.

Objective

This meta-analysis aims to evaluate the long-term cardiovascular risks associated with PPI use, analyzing pooled data from both observational studies and RCTs to assess the impact of PPIs on ischemic stroke, myocardial infarction, cardiac arrest, and cardiovascular mortality.

Methods

A systematic literature search was conducted in PubMed, Embase, Cochrane Library, and Web of Science to identify eligible studies. Inclusion criteria required studies to report cardiovascular outcomes in PPI users compared to non-users, placebo, or H2 blockers, with a minimum follow-up of two years. Data extraction and risk of bias assessment were conducted independently by two reviewers. Pooled effect sizes were calculated using a random-effects model, and heterogeneity was assessed using the I² statistic. Subgroup analyses were performed based on age, PPI dosage, and study design. Publication bias was evaluated using Egger’s and Begg’s tests, with statistical significance set at p < 0.05.

Results

Eight studies, including 8,356 participants, were included in the meta-analysis. PPI use was significantly associated with an increased risk of ischemic stroke (OR: 1.18, 95% CI: 1.09–1.28, p < 0.001, I² = 32%), myocardial infarction (OR: 1.25, 95% CI: 1.14–1.38, p < 0.001, I² = 45%), cardiac arrest (OR: 1.42, 95% CI: 1.19–1.71, p < 0.01, I² = 51%), and cardiovascular mortality (OR: 1.21, 95% CI: 1.12–1.31, p < 0.001, I² = 38%). Subgroup analysis revealed that the risk was higher in older adults (>60 years, OR: 1.30, 95% CI: 1.19–1.42, p < 0.001) and those receiving high-dose PPI therapy (OR: 1.35, 95% CI: 1.22–1.49, p < 0.001, I² = 52%). No significant publication bias was detected.

Conclusion

This meta-analysis links long-term PPI use to higher risks of cardiovascular events, especially in older adults and high-dose users. Clinicians should evaluate prolonged use carefully. Large-scale RCTs are needed for confirmation.

Zitieren

APA

Abbas, M. R., Hussain, H., Abbas, M., Qazi, U., Rafique, M., Batool, I., & Mir, A. (2025). The Long-Term Cardiovascular Risks of Proton Pump Inhibitors (PPIs): A Meta-Analysis of Observational and Randomized Trials. Indus Journal of Bioscience Research, 3(3), 77-83. https://doi.org/10.70749/ijbr.v3i3.913

Vancouver

Abbas MR, Hussain H, Abbas M, Qazi U, Rafique M, Batool I, et al. The Long-Term Cardiovascular Risks of Proton Pump Inhibitors (PPIs): A Meta-Analysis of Observational and Randomized Trials. Indus Journal of Bioscience Research. 2025;3(3):77-83. doi:10.70749/ijbr.v3i3.913

BibTeX
@article{Abbas2025,
  author = {Abbas, Muhammad Raza and Hussain, Hamna and Abbas, Mudassir and Qazi, Urooba and Rafique, Mamoona and Batool, Iqra and Mir, Adeen},
  title = {The Long-Term Cardiovascular Risks of Proton Pump Inhibitors (PPIs): A Meta-Analysis of Observational and Randomized Trials},
  journal = {Indus Journal of Bioscience Research},
  year = {2025},
  volume = {3},
  number = {3},
  pages = {77--83},
  doi = {10.70749/ijbr.v3i3.913}
}
Kostenlos starten →